Showing 17,401 - 17,420 results of 121,722 for search '(( 2 e decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.17s Refine Results
  1. 17401

    Fig 5 - by Adam Lampert (413952)

    Published 2024
    “…All the parameters except <i>α</i> and <i>v</i> are the same in all the panels: Eq (<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1011996#pcbi.1011996.e002" target="_blank">2</a>) is considered, where <i>b</i> is given by Eqs (<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1011996#pcbi.1011996.e007" target="_blank">6</a>–<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1011996#pcbi.1011996.e009" target="_blank">8</a>) with <i>r</i> = 2 and <i>a</i> = 0.08 USD<sup>‒1</sup>, and <i>G</i> is given by Eq (<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1011996#pcbi.1011996.e005" target="_blank">4</a>). …”
  2. 17402

    DataSheet5_A Novel Age-Related Circular RNA Circ-ATXN2 Inhibits Proliferation, Promotes Cell Death and Adipogenesis in Rat Adipose Tissue-Derived Stromal Cells.ZIP by Xing-Hui Song (11665903)

    Published 2021
    “…H and E staining showed that the diameter of adipocytes increased; however, the number of cells decreased in old rats. …”
  3. 17403

    High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation by Michiel G. H. Betjes (8407413)

    Published 2020
    “…</p><p>Methods</p><p>Recipients of a kidney transplant in the period 2007–2013 were (N = 365) were included. …”
  4. 17404

    Fig 5 - by Emma Peel (5518703)

    Published 2021
    “…<i>pecorum</i> MarsBar and IPTaLE elementary bodies with 125μg/mL of PhciCath5 caused a significant decrease in infectious progeny in both serovars. …”
  5. 17405
  6. 17406
  7. 17407
  8. 17408
  9. 17409

    Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAF<sup>V600E</sup> Mutant Melanom... by Brian D. Cholewa (1342671)

    Published 2015
    “…However, the clinical efficacy of Plk1 inhibition has not emulated the preclinical success, stressing an urgent need for a better understanding of Plk1 signaling. This study addresses that need by utilizing a quantitative proteomics strategy to compare the proteome of BRAF<sup>V600E</sup> mutant melanoma cells following treatment with the Plk1-specific inhibitor BI 6727. …”
  10. 17410

    Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAF<sup>V600E</sup> Mutant Melanom... by Brian D. Cholewa (1342671)

    Published 2015
    “…However, the clinical efficacy of Plk1 inhibition has not emulated the preclinical success, stressing an urgent need for a better understanding of Plk1 signaling. This study addresses that need by utilizing a quantitative proteomics strategy to compare the proteome of BRAF<sup>V600E</sup> mutant melanoma cells following treatment with the Plk1-specific inhibitor BI 6727. …”
  11. 17411
  12. 17412
  13. 17413
  14. 17414

    Comparison of the effect of IFN-γ in maturing cells and non-maturing PLB-985 cells. by Michael A. Ellison (789371)

    Published 2017
    “…The DMSO plus IFN-γ versus DMSO fold change models the effect of IFN-γ on maturing cells whereas the IFN-γ versus untreated fold change represents its effect on non-maturing cells. Graphs A, B and C show the results for those genes where the DMSO plus IFN-γ versus DMSO fold change (increase or decrease) was greater than 5 fold, 2 to 5 fold or less than 2 fold, respectively.…”
  15. 17415
  16. 17416
  17. 17417
  18. 17418
  19. 17419
  20. 17420